|
Genpharmasec Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
62.02 Cr.
|
P/BV
|
0.96
|
Book Value (Rs.)
|
1.17
|
|
52 Week High/Low (Rs.)
|
2/1
|
FV/ML
|
1/1
|
P/E(X)
|
51.38
|
|
Bookclosure
|
23/07/2024
|
EPS (Rs.)
|
0.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR |
| FaceValue | 1.00 | 1.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 33.72 | 30.41 |
| Total Operating Revenues | 33.72 | 30.41 |
| | | |
| Other Income | 3.06 | 0.66 |
| Total Revenue | 36.78 | 31.06 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 0.87 | 0.00 |
| Purchase Of Stock-In Trade | 28.07 | 23.39 |
| Operating And Direct Expenses | 0.00 | 0.01 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.61 | 0.83 |
| Employee Benefit Expenses | 0.99 | 0.76 |
| Finance Costs | 0.43 | 0.41 |
| Depreciation And Amortisation Expenses | 0.81 | 0.04 |
| Other Expenses | 3.12 | 5.36 |
| Total Expenses | 34.90 | 30.81 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.88 | 0.25 |
| | | |
| Profit/Loss Before Tax | 1.88 | 0.25 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 0.69 | 0.00 |
| Deferred Tax | -0.04 | 0.42 |
| Total Tax Expenses | 0.65 | 0.42 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1.23 | -0.17 |
| | | |
| Profit/Loss From Continuing Operations | 1.23 | -0.17 |
| | | |
| Profit/Loss For The Period | 1.23 | -0.17 |
| | | |
| Minority Interest | -0.02 | 0.04 |
| Consolidated Profit/Loss After MI And Associates | 1.21 | -0.13 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | 0.02 | -0.01 |
| Diluted EPS (Rs.) | 0.02 | -0.01 |
